Tumor-specific CD4(+) suppressor T-cell clone capable of inhibiting rejection of syngeneic sarcoma in A/J mice

International Journal of Cancer

Volumn 87, Issue 5, 2000, Pages 680-687

  Fu, Tihui ^a   Shen, Yuan ^a   Fujimoto, Shigeyoshi ^a  

^a KOCHI MEDICAL SCHOOL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN;

ANIMAL CELL; ANTIGEN SPECIFICITY; ARTICLE; CELL PROLIFERATION; GRAFT REJECTION; GROWTH INHIBITION; IMMUNE RESPONSE; MAJOR HISTOCOMPATIBILITY COMPLEX RESTRICTION; MOLECULAR CLONING; MOUSE; NONHUMAN; PRIORITY JOURNAL; RECEPTOR DOWN REGULATION; SARCOMA; T LYMPHOCYTE SUBPOPULATION; TUMOR GROWTH; TUMOR IMMUNITY; TUMOR SUPPRESSOR GENE;

ADOPTIVE TRANSFER; ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGEN-PRESENTING CELLS; ANTIGENS, CD4; CD4-POSITIVE T-LYMPHOCYTES; CLONE CELLS; CYTOKINES; EPITOPES, T-LYMPHOCYTE; METHYLCHOLANTHRENE; MICE; MICE, INBRED A; MICE, INBRED BALB C; MICE, NUDE; PHENOTYPE; SARCOMA, EXPERIMENTAL; T-LYMPHOCYTES, CYTOTOXIC; T-LYMPHOCYTES, REGULATORY;

EID: 0033866236     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/1097-0215(20000901)87:5<680::AID-IJC10>3.0.CO;2-P     Document Type: Article

References (38)

1. ABBAS, A.K., MURPHY, K.M. and SHER, A., Functional diversity of helper T lymphocytes. Nature (Lond.), 383, 787-793 (1996).
2. + beta islet cell-reactive T cell clones that suppress autoimmune diabetes in nonobese diabetic mice. J. exp. Med., 182, 87-97 (1995).
3. ARUGA, A., ARUGA, E., TANIGAWA, K., BISHOP, D.K., SONDAK, V.K. and CHANG, A.E., Type 1 versus type 2 cytokine release by V beta T cell subpopulations determines in vivo antitumor reactivity: IL-10 mediates a suppressive role. J. Immunol., 159, 664-673 (1997).
4. + T cell-mediated immunity. J. exp. Med., 168, 2193-2206 (1988).
5. AWWAD, M. and NORTH, R.J., Radiosensitive barrier to T-cell-mediated adoptive immunotherapy of established tumors. Cancer Res., 50, 2228-2233 (1990).
6. BENDELAC, A., RIVERA, M.N., PARK, S.H. and ROARK, J.H., Mouse CD1-specific NK1 T cells: development, specificity, and function. Annu. Rev. Immunol., 15, 535-562 (1997).
7. BROWN, P.D., WAKEFIELD, L.M., LEVINSON, A.D. and SPORN, M.B., Physicochemical activation of recombinant latent transforming growth factor-beta's 1, 2, and 3. Growth Factors, 3, 35-43 (1990).
8. + T cell response to repetitive stimulation with antigen-presenting cells in vitro: implications in designing antigen-presenting cell-based tumor vaccines. J. Immunol., 162, 5576-5583 (1999).
9. CHAVIN, K.D., QIN, L., YON, R., LIN, J., YAGITA, H. and BROMBERG, J.S., Anti-CD2 MAbs suppress cytotoxic lymphocyte activity by the generation of Th2 suppressor cells and receptor blockade. J. Immunol., 152, 3729-3739 (1994).
10. CHEN, Y., KUCHROO, V.K., INOBE, J., HAFLER, D.A. and WEINER, H.L., Regulatory T cell clones induced by oral tolerance: suppression of auto-immune encephalomyelitis. Science. 265, 1237-1240 (1994).
11. CHOUAIB, S., ASSELIN-PATUREL, C., MAMI-CHOUAIB, F., CAIGNARD, A. and BLAY, J.Y., The host-tumor immune conflict: from immunosuppression to resistance and destruction. Immunol. Today, 18, 493-497 (1997).
12. FUJIMOTO, S., GREENE, M.I. and SEHON, A.H., Regulation of the immune response to tumor antigens. I. Immunosuppressor cells in tumor-bearing hosts. J. Immunol., 116, 791-799 (1976a).
13. FUJIMOTO, S., GREENE, M.I. and SEHON, A.H., Regulation of the immune response to tumor antigens. II. The nature of immunosuppressor cells in tumor-bearing hosts. J. Immunol., 116, 800-806 (1976b).
14. FUJIMOTO, S., MATSUZAWA, T., NAKAGAWA, K. and TADA, T., Cellular interaction between cytotoxic and suppressor T cells against syngeneic tumors in the mouse. Cell. Immunol., 38, 378-387 (1978).
15. GHOSH, P., KOMSCHLIES, K.L., CIPPITELLI, M., LONGO, D.L., SUBLESKI, J., YE, J., SICA, A., YOUNG, H.A., WILTROUT, R.H. and OCHOA, A.C., Gradual loss of T-helper 1 populations in spleen of mice during progressive tumor growth. J. nat. Cancer Inst., 87, 1478-1483 (1995).
16. + T-cell subset inhibits antigen-specific T-cell responses and PREVENTS COLITIS. Nature (Lond.), 389, 737-742 (1997).
17. + suppressor T cell, NY4.2, in the prevention of autoimmune IDDM in NOD mice. J. Autoimmun., 10, 299-307 (1997).
18. JIAO, Y. and FUJIMOTO, S., Sequential T cell response involved in tumor rejection of sarcoma, Meth A, in syngeneic mice. Jpn. J. Cancer Res., 89, 657-665 (1998).
19. KOBAYASHI, M., KOBAYASHI, H., POLLARD, R.B. and SUZUKI, F., A PATHOGENIC ROLE OF Th2 cells and their cytokine products on the pulmonary metastasis of murine B16 melanoma. J. Immunol., 160, 5869-5873 (1998).
20. LAFAILLE, J.J., KEERE, F.V., HSU, A.L., BARON, J.L., HAAS, W., RAINE, C.S. and TONEGAWA, S., Myelin basic protein-specific T helper 2 (Th2) cells cause experimental autoimmune encephalomyelitis in immunodeficient hosts rather than protect them from the disease. J. exp. Med., 186, 307-312 (1997).
21. LUTZ, C.T., GLASEBROOK, A.L. and FITCH, F.W., Alloreactive cloned T cell lines. IV. Interaction of alloantigen and T cell growth factors (TCGF) to stimulate cloned cytolytic T lymphocytes. J. Immunol., 127, 391-392 (1981).
22. MAEDA, H., TAKATA, M., TAKAHASHI, S., OGOSHI, S. and FUJIMOTO, S., Adoptive transfer of a Th2-like cell line prolongs MHC class II antigen disparate skin allograft survival in the mouse. Int. Immunol., 6, 855-862 (1994).
23. MARTINOTTI, A., STOPPACCIARO, A., VAGLIANI, M., MELANI, C., SPREAFICO, F., WYSOCKA, M., PARMIANI, G., TRINCHIERI, G. and COLOMBO, M.P., CD4 T cells inhibit in vivo the CD8-mediated immune response against murine colon carcinoma cells transduced with interleukin-12 genes. Europ. J. Immunol., 25, 137-146 (1995).
24. MOORE, K.W., O'GARRA, A., DE WAAL MALEFYT, R., VIEIRA, P. and MOSMANN, T.R., Interleukin-10. Ann. Rev. Immunol., 11, 165-190 (1993).
25. MOSMANN, T.R. and COFFMAN, R.L., TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties. Ann. Rev. Immunol., 7, 145-173 (1989).
26. MOSMANN, T.R., SCHUMACHER, J.H., FIORENTINO, D.F., LEVERAH, J., MOORE, K.W. and BOND, M.W., Isolation of monoclonal antibodies specific for IL-4, IL-5, IL-6 and a new Th2-specific cytokine (IL-10), cytokine synthesis inhibitory factor, by using a solid phase radioimmunoadsorbent assay. J. Immunol., 145, 2938-2945 (1990).
27. NORTH, R.J., Down-regulation of the antitumor immune response. Adv. Cancer Res., 45, 1-43 (1985).
28. + T cells to cause regression of an advanced lymphoma. Immunology, 71, 90-95 (1990).
29. O'HARA, R.M., JR., Antigen-specific suppressor factor: missing pieces in the puzzle. Immunol. Res., 14, 252-262 (1995).
30. PAKALA, S.V., KURRER, M.O. and KATZ, J.D., T helper 2 (Th2) T cells induce acute pancreatitis and diabetes in immune-compromised nonobese diabetic (NOD) mice. J. exp. Med., 186, 299-306 (1997).
31. RANGES, G.E., FIGARI, I.S., ESPEVIK, T. and PALLADINO, M.J., Inhibition of cytotoxic T cell development by transforming growth factor beta and reversal by recombinant tumor necrosis factor alpha. J. exp. Med., 166, 991-998 (1987).
32. 2 fragments from monoclonal IgG of different rat IgG subclasses. J. immunol. Methods, 64, 141-146 (1983).
33. + cytotoxic T-lymphocyte activation in mice. Cancer Res., 56, 5005-5011 (1996).
34. SHIMIZU, J., Zou, J.P., IKEGAME, K., KATAGIRI, T., FUJIWARA, H. and HAMAOKA, T., Evidence for the functional binding in vivo of tumor rejection antigens to antigen-presenting cells in tumor-bearing hosts. J. Immunol., 146, 1708-1714 (1991).
35. STREMMEL, C., GREENFIELD, E.A., HOWARD, E., FREEMAN, G.J. and KUCHROO, V. K., B7-2 expressed on EL4 lymphoma suppresses antitumor immunity by an interleukin 4-dependent mechanism. J. exp. Med., 189, 919-930 (1999).
36. +) T cells established from murine tumor-infiltrating lymphocytes. J. Immunol., 158, 4846-4854 (1997).
37. + immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production. J. exp. Med., 188, 287-296 (1998).
38. + T cell activity. J. Immunol., 148, 648-655 (1992).